Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Mauna Kea Technologies
  6. News
  7. Summary
    MKEA   FR0010609263

MAUNA KEA TECHNOLOGIES

(MKEA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Mauna Kea Technologies : , Johnson & Johnson Enter Lung Cancer Research Collaboration

09/20/2021 | 05:37am EDT


© MT Newswires 2021
All news about MAUNA KEA TECHNOLOGIES
10/05GLOBAL MARKETS LIVE : Facebook, AB InBev, Qantas, Tesco, Swiss Re...
10/04MAUNA KEA TECHNOLOGIES : Announces 5 Communications Highlighting the Clinical Value of Cel..
PU
10/04Mauna Kea Technologies Announces 5 Communications Highlighting the Clinical Value of Ce..
CI
09/23Mauna Kea Technologies Sa Reports Earnings Results for the Half Year Ended June 30, 202..
CI
09/23MAUNA KEA TECHNOLOGIES : reports first half 2021 financial results
PU
09/20GLOBAL MARKETS LIVE : Universal Music Group, China Evergrande, ENI, Prudential, Microsoft...
09/20MAUNA KEA TECHNOLOGIES : Initiates $15 Million Capital Raise for Two Investors
MT
09/20MAUNA KEA TECHNOLOGIES : Johnson & Johnson Enter Lung Cancer Research Collaboration
MT
09/20Mauna Kea Technologies Announces New Clinical Study and Research Collaboration Agreemen..
CI
08/25GLOBAL MARKETS LIVE : Kering, Delta Air Lines, Pfizer, Moderna, Sony...
More news
Financials
Sales 2021 8,39 M 9,76 M 9,76 M
Net income 2021 -14,2 M -16,6 M -16,6 M
Net Debt 2021 27,4 M 31,8 M 31,8 M
P/E ratio 2021 -2,68x
Yield 2021 -
Capitalization 46,0 M 53,6 M 53,5 M
EV / Sales 2021 8,74x
EV / Sales 2022 7,44x
Nbr of Employees 99
Free-Float 96,9%
Chart MAUNA KEA TECHNOLOGIES
Duration : Period :
Mauna Kea Technologies Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MAUNA KEA TECHNOLOGIES
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Last Close Price 1,04 €
Average target price 2,13 €
Spread / Average Target 105%
EPS Revisions
Managers and Directors
Robert L. Gershon Chief Executive Officer & Director
Christophe Lamboeuf CFO & Deputy Chief Executive Officer
Sacha Loiseau Chairman
François Lacombe Chief Scientific Officer
Aline Criton Director-Regulatory & Clinical Affairs
Sector and Competitors
1st jan.Capi. (M$)
MAUNA KEA TECHNOLOGIES-20.97%54
SARTORIUS AG69.57%44 406
BIOTAGE AB (PUBL)84.60%1 946
REVENIO GROUP OYJ12.03%1 743
CELLAVISION AB (PUBL)35.50%1 154
VAREX IMAGING CORPORATION62.29%1 067